EyePoint faces clinical, commercial hurdles despite DME, AMD progress and solid funding through 2027. Read why EYPT stock is ...

It’s time for the FDA to re-evaluate its decision to authorise Q-Collar, say James Smoliga and Mu Yang A wearable “brain ...

Aicuris has reported the success of a phase 3 trial, which has demonstrated the superiority of oral antiviral pritelivir ...

A major pillar of the Voting Rights Act that aims to prevent racial discrimination during the redistricting process is in the ...

Runpod is a cloud platform specializing in GPU-based infrastructure for artificial intelligence applications. The company ...

The Nov. 5 case will decide billions of dollars in trade and significantly influence the country's trade policy.

The Min Joong-ki-led special counsel team investigating suspicions related to Kim Keon-hee has launched a seizure and search ...

Justice Brett Kavanaugh questioned when the provision requiring race-based redistricting in the Voting Rights Act would ...

The ACHIEVE-5 trial (ClinicalTrials.gov identifier: NCT06109311) was a randomized, double-blind, placebo-controlled study that included 546 T2D patients with inadequate glycemic control on insulin ...

The Louisiana v. Callais case would have far-reaching consequences on congressional maps and the Voting Rights Act.

The Supreme Court appeared ready Wednesday to rule against requiring Louisiana to have a second Black-majority district.

Financially, Compass Pathways is well-capitalized with $221.9 million in cash, funding operations into 2027. Click here to ...